We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …

I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-2006. The estimates imply that chemotherapy innovation accounted for at least one-sixth of the decline in French cancer …

increased more in some states than in others?" One of the conclusions I drew from that study was that medical innovation …-Berman express deep skepticism about my study's conclusion that medical innovation has played a very important role in recent U …

the presence of such products on innovation and consumer welfare. For a given number of buyers, platform liability … increases innovation by reducing the competitive pressure faced by innovative products. However, there can be a misalignment of … intended effect on innovation. Platform liability tends to increase (decrease) innovation and consumer welfare when the …

-enhancing innovation incentives by a monopolist—who derives revenues solely from disclosing user data to third parties—and consumer surplus …. If the share of privacy-concerned users is sufficiently small, privacy regulation has a negative effect on innovation and … effect on innovation. In this case, there is no trade-off between privacy and innovation and users always benefit from …

Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months)- about 44% of the total increase in longevity -and … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …

-enhancing innovation incentives by a monopolist—who derives revenues solely from disclosing user data to third parties—and consumer surplus …. If the share of privacy-concerned users is sufficiently small, privacy regulation has a negative effect on innovation and … effect on innovation. In this case, there is no trade-off between privacy and innovation and users always benefit from …

the presence of such products on innovation and consumer welfare. For a given number of buyers, platform liability … increases innovation by reducing the competitive pressure faced by innovative products. However, there can be a misalignment of … intended effect on innovation. Platform liability tends to increase (decrease) innovation and consumer welfare when the …

This paper investigates the choice of an intellectual protection regime for a process innovation. We set up a multi … the probability that the right is upheld by the court, the cost of imitating a patented innovation relative to the cost of … imitating a secret innovation, and the innovation size defined as the extent of the cost reduction. The choice of the protection …